Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1853 1
1870 1
1871 2
1945 1
1951 2
1952 2
1954 1
1964 1
1967 1
1968 4
1969 5
1970 8
1971 15
1972 13
1973 10
1974 6
1975 10
1976 9
1977 9
1978 9
1979 8
1980 13
1981 9
1982 4
1983 8
1984 11
1985 8
1986 10
1987 15
1988 33
1989 32
1990 44
1991 53
1992 45
1993 49
1994 49
1995 38
1996 63
1997 67
1998 102
1999 90
2000 82
2001 88
2002 108
2003 100
2004 127
2005 138
2006 168
2007 167
2008 183
2009 160
2010 213
2011 265
2012 297
2013 377
2014 545
2015 748
2016 851
2017 968
2018 1215
2019 1388
2020 1583
2021 1771
2022 1826
2023 1660
2024 1678
2025 1785
2026 628

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,149 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the clinic. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed rese …
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the …
Medical Cannabis.
Ebbert JO, Scharf EL, Hurt RT. Ebbert JO, et al. Mayo Clin Proc. 2018 Dec;93(12):1842-1847. doi: 10.1016/j.mayocp.2018.09.005. Mayo Clin Proc. 2018. PMID: 30522595 Review.
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In …
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United S …
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain.
Petzke F, Tölle T, Fitzcharles MA, Häuser W. Petzke F, et al. CNS Drugs. 2022 Jan;36(1):31-44. doi: 10.1007/s40263-021-00879-w. Epub 2021 Nov 21. CNS Drugs. 2022. PMID: 34802112 Free PMC article. Review.
Management of neuropathic pain presents an unmet clinical need, with less than 50% of patients achieving substantial pain relief with medications currently recommended such as pregabalin, gabapentin, duloxetine and various tricyclic antidepressants. It has been suggested that …
Management of neuropathic pain presents an unmet clinical need, with less than 50% of patients achieving substantial pain relief with medica …
Practical considerations in medical cannabis administration and dosing.
MacCallum CA, Russo EB. MacCallum CA, et al. Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. Eur J Intern Med. 2018. PMID: 29307505 Review.
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certain nations, this ignorance of cannabis pharmacology and therapeutics has become untenable. ...Dose initiation should commence at modes …
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certai …
Medical cannabis in the UK: From principle to practice.
Schlag AK, Baldwin DS, Barnes M, Bazire S, Coathup R, Curran HV, McShane R, Phillips LD, Singh I, Nutt DJ. Schlag AK, et al. J Psychopharmacol. 2020 Sep;34(9):931-937. doi: 10.1177/0269881120926677. Epub 2020 Jun 10. J Psychopharmacol. 2020. PMID: 32522058 Free PMC article. Review.
BACKGROUND: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine would now be available on the NHS. ...In marked contrast, a recent patient survey by the Centre for Medical Cannabis (Couch, 2020) …
BACKGROUND: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine woul …
[Medical cannabis].
Kochen S. Kochen S. Salud Colect. 2022 Mar 3;18:e3991. doi: 10.18294/sc.2022.3991. Salud Colect. 2022. PMID: 35900986 Spanish.
In this issue, we take on alternatives regarding the use of medical cannabis from this perspective. Health research and its contribution to knowledge - in particular with respect to the development of new pharmaceuticals - represents not only a challenge related to …
In this issue, we take on alternatives regarding the use of medical cannabis from this perspective. Health research and its co …
Medical cannabis and cannabidiol: A new harvest for Malawi.
Bandawe G. Bandawe G. Malawi Med J. 2022 Jun;34(2):138-142. doi: 10.4314/mmj.v34i2.10. Malawi Med J. 2022. PMID: 35991815 Free PMC article. Review.
In February 2020 parliament passed the Cannabis Regulation Bill (2020) which regulates the cultivation and production of industrial hemp and medical cannabis. ...This special communication provides some basic information on cannabis and discusses its h …
In February 2020 parliament passed the Cannabis Regulation Bill (2020) which regulates the cultivation and production of industrial h …
Medical Cannabis for Older Patients.
Minerbi A, Häuser W, Fitzcharles MA. Minerbi A, et al. Drugs Aging. 2019 Jan;36(1):39-51. doi: 10.1007/s40266-018-0616-5. Drugs Aging. 2019. PMID: 30488174 Review.
Interest in the medicinal use of cannabis and cannabinoids is mounting worldwide. Fueled by enthusiastic media coverage, patients perceive cannabinoids as a natural remedy for many symptoms. ...This review provides a summary of the evidence for use of cannabinoids, and …
Interest in the medicinal use of cannabis and cannabinoids is mounting worldwide. Fueled by enthusiastic media coverage, patients per …
Medical Cannabis in Canadian Schools: A Scoping Review of Existing Policies.
Awal M, Kelly LE, Anderson J, Brace T, Brown C, Buettner T, King PM, Klemmer J, Lougheed T, O'Shea K, Mansell H. Awal M, et al. Cannabis Cannabinoid Res. 2022 Dec;7(6):758-768. doi: 10.1089/can.2021.0199. Epub 2022 Oct 14. Cannabis Cannabinoid Res. 2022. PMID: 36251467
Objective: An increasing number of children and youth in Canada are taking medical cannabis for complex medical conditions. While they deserve safe and consistent access to pharmacotherapy throughout the day, administrative policies on cannabis use in …
Objective: An increasing number of children and youth in Canada are taking medical cannabis for complex medical conditi …
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA, Raup-Konsavage WM, Vrana KE. Legare CA, et al. Pharmacology. 2022;107(3-4):131-149. doi: 10.1159/000521683. Epub 2022 Jan 28. Pharmacology. 2022. PMID: 35093949 Free article. Review.
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). SUMMARY: In the pre …
While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited …
12,149 results
You have reached the last available page of results. Please see the User Guide for more information.